51Talk Online Education Group to Present at Sidoti Virtual Investor Conference on August 20-21, 2025

PR Newswire


SINGAPORE
, Aug. 15, 2025 /PRNewswire/ — 51Talk Online Education Group (NYSE American: COE) announced Mr. David Chung, the Company’s Investor Relations Vice President, will present and host one-on-one meetings with investors at the Sidoti August Virtual Investor Conference, taking place on August 20-21, 2025.

The presentation will begin at 8:30 a.m. ET on August 20, 2025 and can be accessed live here: https://sidoti.zoom.us/webinar/register/WN_3aUxJgJvTKePjJM9GQk-Ew. 51Talk Online Education Group will also host virtual one-on-ones with investors on Wednesday and Thursday, August 20-21, 2025. To register for the presentation or one-on-ones, visit www.sidoti.com/events. Registration is free and you don’t need to be a Sidoti client.

About Sidoti Events, LLC (“Events”) and Sidoti & Company, LLC (“Sidoti”)

In 2023, Sidoti & Company, LLC, Sidoti & Company, LLC (www.sidoti.com) formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the over 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million$5 billion market cap range. Sidoti’s coverage universe comprises approximately 150 equities, of which almost 70 percent participate in the firm’s rapidly growing Company Sponsored Research (“CSR”) and Lighthouse Equity Research (“Lighthouse”) programs. Events is a leading provider of corporate access through the many investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Events benefits from Sidoti’s small- and microcap-focused nationwide sales force, which has connections with over 2,500 institutional relationships in North America.  This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

About 51Talk Online Education Group:

51Talk Online Education Group (NYSE American: COE) is a global online education platform with core expertise in English education. The Company’s mission is to make quality education accessible and affordable. The Company’s online and mobile education platforms enable students to take live interactive English lessons on demand. The Company connects its students with highly qualified teachers using a shared economy approach, and employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students.

INVESTOR CONTACTS:

51Talk Online Education Group
David Chung
Investor Relations Vice President
[email protected]

 

Cision View original content:https://www.prnewswire.com/news-releases/51talk-online-education-group-to-present-at-sidoti-virtual-investor-conference-on-august-20-21-2025-302530924.html

SOURCE 51Talk Online Education Group

Li Auto Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025

BEIJING, China, Aug. 15, 2025 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it will report its unaudited financial results for the second quarter of 2025 before the U.S. market opens on Thursday, August 28, 2025.

The Company’s management will hold an earnings conference call on Thursday, August 28, 2025, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day.

For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will receive the conference call access information, including dial-in numbers, passcode, and a unique access PIN. To join the conference, please dial the number provided, enter the passcode followed by your PIN, and you will join the conference instantly.

Participant Online Registration: https://s1.c-conf.com/diamondpass/10048990-4d8gt5.html

A replay of the conference call will be accessible through September 4, 2025, by dialing the following numbers:

United States: +1-855-883-1031
Mainland, China: +86-400-1209-216
Hong Kong, China: +852-800-930-639
International: +61-7-3107-6325
Replay PIN: 10048990
   

A live and archived webcast of the conference call will also be available at the Company’s investor relations website at https://ir.lixiang.com.

About Li Auto Inc.

Li Auto Inc. is a leader in China’s new energy vehicle market. The Company designs, develops, manufactures, and sells premium smart electric vehicles. Its mission is: Create a Mobile Home, Create Happiness (创造移动的家,创造幸福的家). Through innovations in product, technology, and business model, the Company provides families with safe, convenient, and comfortable products and services. Li Auto is a pioneer in successfully commercializing extended-range electric vehicles in China. While firmly advancing along this technological route, it builds platforms for battery electric vehicles in parallel. The Company leverages technology to create value for users. It concentrates its in-house development efforts on proprietary range extension systems, innovative electric vehicle technologies, and smart vehicle solutions. The Company started volume production in November 2019. Its current model lineup includes a high-tech flagship family MPV, four Li L series extended-range electric SUVs, and one Li i series battery electric SUV. The Company will continue to expand its product lineup to target a broader user base.

For more information, please visit: https://ir.lixiang.com.

For investor and media inquiries, please contact:

Li Auto Inc.
Investor Relations
Email: [email protected]

Christensen Advisory
Roger Hu
Tel: +86-10-5900-1548
Email: [email protected]



Viomi Technology Co., Ltd Announces Preliminary First Half 2025 Financial

Expects Revenue to Grow Over 70% Year Over Year

GUANGZHOU, China, Aug. 15, 2025 (GLOBE NEWSWIRE) — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced its preliminary, unaudited revenue for the first half of 2025.

Drawing from the Company’s preliminary, unaudited financial results and operational performance, Viomi currently expects to report total revenue exceeding RMB1.4 billion, representing a year-over-year increase of more than 70% from the first half of 2024. The anticipated increase is primarily driven by the rising sales for household water purification equipment, further supported by national subsidy policies. This growth also serves as a testament to the high degree of consumer recognition for the Company’s technological strength.

Mr. Xiaoping Chen, Founder and CEO of Viomi, commented, “In the first half of 2025, underpinned by disciplined execution and supportive government policies, we delivered robust revenue growth coupled with solid operational performance. Looking ahead, as public health consciousness continues to heighten and the adoption of household water purification systems accelerates, we believe this favorable industry dynamics will underpin our long-term, sustainable growth. Capitalizing on this momentum, we will continue to leverage our R&D capabilities to deliver innovative, high-quality solutions that address the evolving needs of our broader consumers base.”

The preliminary financial results presented in this announcement are based on the most current information available to the management of the Company. These results are unaudited and subject to the completion of the Company’s financial reporting processes, reviews, and audit, which could result in adjustments to the final numbers.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Among other things, the estimated revenue and income from operations from the Continuing Businesses, the business outlook and quotations from management in this announcement, as well as Viomi’s strategic and operational plans, contain forward-looking statements. Viomi may also make written or oral forward-looking statements in its periodic reports to the United States Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to Fourth parties. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s growth strategies; the cooperation with Xiaomi, the recognition of the Company’s brand; trends and competition in global IoT-enabled smart home market; development and commercialization of new products, services and technologies; governmental policies and relevant regulatory environment relating to the Company’s industry and/or aspects of the business operations and general economic conditions in China and around the globe, and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

About Viomi Technology

Viomi’s mission is “AI for Better Water,” utilizing AI technology to provide better drinking water solutions for households worldwide.

As an industry-leading technology company in home water systems, Viomi has developed a distinctive “Equipment + Consumables” business model. By leveraging its expertise in AI technology, intelligent hardware and software development, the Company simplifies filter replacement and enhances water quality monitoring, thereby increasing the filter replacement rate. Its continuous technological innovations extend filter lifespan and lower user costs, promoting the adoption of water purifiers and supporting a healthy lifestyle while effectively addressing the rising global demand for cleaner, fresher and healthier drinking water. The Company operates a world-leading “Water Purifier Gigafactory” with an integrated industrial chain that boasts optimal efficiency and facilitates continuous breakthroughs in water purification. This state-of-the-art facility enables Viomi to achieve economies of scale and accelerate the global popularization of residential water filtration.

For more information, please visit: http://ir.viomi.com.

For investor and media inquiries, please contact:

In China:

Viomi Technology Co., Ltd
Claire Ji
E-mail: [email protected]

Piacente Financial Communications
Hui Fan
Tel: +86-10-6508-0677
E-mail: [email protected]

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: [email protected]



SIGMA LITHIUM REPORTS 2Q25 RESULTS: DELIVERS ON-TARGET PRODUCTION, FURTHER COST REDUCTIONS AND DELEVERAGING

PR Newswire

HIGH
LIG
HTS

  • Achieved 68,368t of lithium oxide concentrate in 2Q25, a 38% year-on-year increase and slightly above the quarterly target of 67,500t.
  • Maintained cost under control and below the target over previous quarter driven by economies of scale, stable plant gate costs, and efficient logistics
    :

    • CIF China cash operating costs of $442/t in 2Q25, 12% below target of $500/t.
    • All-in sustaining cash costs (AISC) totaled $594/t in 2Q25, 10% below target of $660/t. 
  • Reported gross sales revenue – lithium oxide concentrate of $21.1 million, 60.3% decrease compared to 2Q24, reflecting a deliberate strategy to withhold product during intense price volatility, preserving pricing power and protecting long-term margins.
  • Advanced Plant 2 construction, completed key site preparation activities and advanced procurement strategy for critical equipment, keeping the project on track to double nameplate capacity to 520,000 tonnes per year. 

Conference Call Information

The Company will hold a conference call to discuss its financial results for the second quarter of 2025 at 8:00 a.m. ET on Friday, August 15, 2025. To register for the call, please proceed through the following link Register here

SÃO PAULO, Aug. 15, 2025 /PRNewswire/ — Sigma Lithium Corporation (TSXV/NASDAQ: SGML, BVMF: S2GM34), a leading global lithium producer dedicated to powering the next generation of electric vehicles with carbon neutral, socially and environmentally sustainable lithium concentrate, reports its results for the second quarter ended June 30, 2025.

Ana Cabral, Co-Chairperson and CEO, commented:Our second-quarter performance highlights the strength of Sigma Lithium’s low-cost, large-scale operations and disciplined commercial strategy. We managed to further decrease our costs consolidating our operational resilience. We maintained production cadence at 68kt and are comfortably on track to deliver on our annual production target of 270kt while preserving pricing power in a volatile market —while upholding some of the highest health and safety standards in the battery materials supply chain: we celebrated two years without accidents or fatalities. These results demonstrate our ability to execute consistently, create value through market cycles, and reinforce our leading position as a global integrated industrial and mineral lithium producer”.

Table 1. Summary of Key Operational and Financial Metrics


Production and Sales 


Unit


2Q25


2Q24


Var.
Y/Y(%)


1Q25


Var.
Q/Q(%)

Production Volumes

tonnes

68,368

49,389

38 %

68,308

0 %

Sales Volumes

tonnes

40,350

52,572

-23 %

61,584

-34 %

Average grade of shipped product

% of Li2O

5.2

5.5

-0 %

5.0

0 %

COGS

$/t

584

566

3 %

556

5 %

Operating Cash Cost at Plant Gate (2)

$/t

348

364

-4 %

349

-0 %

Operating Cash Cost CIF China (2)

$/t

442

515

-14 %

458

-3 %

All-in Sustaining Cash Cost (2)

$/t

594

779

-24 %

622

-4 %


Financial Performance


Unit 


2Q25


2Q24


Var.
Y/Y(%)


1Q25


Var.
Q/Q(%)

Sales Revenue(3)

$ 000s

21,148

56,311

-62 %

47,833

-56 %

COGS

$ 000s

(23,564)

(29,766)

-20 %

(34,217)

-31 %

Average Revenue per Tonne (3)

$/t

524

1071

-51 %

777

-32 %

EBITDA(4)

$ 000s

(16,876)

8,639

-295 %

10,010

-268 %

Stock-based compensation

$ 000s

200

1,943

-110 %

1,416

-114 %

Adjusted EBITDA(4)

$ 000s

(17,077)

10,582

-261 %

11,426

-249 %

Net Income

$ 000s

(18,857)

(10,848)

73 %

4,728

-499 %

Cash and Cash Equivalents, at the end of the respective period

$ 000s

15,113

75,330

-80 %

31,111

-51 %

Revenues and Production

Sigma Lithium reported revenues of $21.1 million for 2Q25, representing a 62% year-on-year decrease and a 56% decrease over 1Q25 revenues. Sales volumes totaled 40,350 tonnes in 2Q25, down 23% from 2Q24 and down 34% compared to 1Q25, primarily due to our disciplined commercial strategy, under which we temporarily withheld product from the market during periods of intense price volatility to preserve pricing power and protect long-term margins.

The Company reported production volumes of 68,368 tonnes in 2Q25, slightly higher than quarter production target of 67,500 tonnes, and 38% higher compared to 2Q24. The Company expects its FY25 production to reach 270,000 tonnes.

Costs

The Company reported a cost of sales of $23.6 million for 2Q25, reflecting a 20% decrease compared to 2Q24 and a 31% decrease compared to 1Q25. On a per-tonne basis, the cost of sales averaged $584 per tonne of productsold, which represents a 3% increase year-over-year and a 5% increase from 1Q25.

The Company’s operating cash costs remain among the lowest in the industry, with CIF China cash operating costs averaging $442/t. This represents a 3% decrease from $458/t in 1Q25 and remains 12% below the 2025 cost target of $500/t. This reduction was supported by economies of scale from higher production volumes, stable plant gate costs, efficient freight and port operations, and lower CIF charges — achieved despite the recognition of ocean freight expenses related to prior-quarter shipments.

All-in sustaining cost (AISC) decreased by approximately 4% to an average of $594/t, remaining below the full-year target of $660/t.

Balance Sheet & Liquidity

As of June 30, 2025, the Company’s cash and cash equivalents totaled $31.1 million, representing a 32% decrease from $45.9 million as of December 31, 2024, primarily driven by operational costs and expenses, as well as the deleveraging of trade finance lines.

The Company reduced its short-term trade finance by approximately $6 million in 2Q25, bringing the balance to $45.5 million as of June 30, 2025. The total amount of short and long-term debts was $166.9 million as of June 30, 2025. The net interest paid in 2Q25 totaled $0.8 million or approximately $12/t of quarterly production.

The Company is evaluating potential long-term prepayment and offtake agreements, in line with standard industry practices. To date, it has maintained full commercial flexibility, with 100% of its production uncommitted. Any agreements executed would form part of the Company’s strategy to optimize its capital structure and support Phase 2 funding alongside BNDES reimbursements.

Operational and Phase 2 Expansion Updates

During the six-month period ended June 30, 2025, Sigma continued to progress on the Phase 2 expansion project, with completion of key site preparation activities including formal earthworks and terracing. The Company remains focused on de-risking execution through strategic alignment of Phase 2 with the proven flowsheet, engineering concepts, and supplier partnerships established in Phase 1.

In parallel, Sigma has undertaken a detailed review of procurement priorities and project execution strategy, reinforcing its commitment to value-driven capital allocation and operational excellence. This includes evaluating optimal timelines for the contracting of long lead equipment and engineering services that will ensure readiness for the next construction milestones.

The Phase 2 expansion remains a transformative opportunity for the Company, with expected additional production capacity of 250,000 tonnes per annum of 5.5% Green Lithium. Together with Phase 1, this would bring the total annual production capacity to 520,000 tonnes of lithium oxide concentrate at Grota do Cirilo.

The Company continues to leverage the synergies and learnings from Phase 1 to enhance the efficiency and sustainability of the Phase 2 implementation, with ramping-up scheduled for 2026.

Qualified Person Disclosure

Please refer to the Company’s National Instrument 43-101 technical report titled “Grota do Cirilo Lithium Project Araçuaí and Itinga Regions, Minas Gerais, Brazil” issued March 31, 2025, which was prepared for Sigma Lithium by Marc-Antoine Laporte, P.Geo, SGS Canada Inc., William van Breugel, P.Eng, SGS Canada Inc., Johnny Canosa, P.Eng, SGS Canada Inc., and Joseph Keane, P. Eng., SGS North America Inc. (the “Technical Report”). The Technical Report is filed on SEDAR and is also available on the Company’s website.

The independent qualified person (QP) for the Technical Report’s mineral resource estimates is Marc-Antoine Laporte P.Geo., M.Sc., of SGS Group in Quebec, Canada. Mr. Laporte is a Qualified Person as defined by Canadian National Instrument 43-101.

Other disclosures in this news release of a scientific or technical nature at the Grota do Cirilo Project have been reviewed and approved by Iran Zan MAIG (Membership number 7566), who is considered, by virtue of his education, experience and professional association, a Qualified Person under the terms of NI 43-101. Mr. Zan is not considered independent under NI 43-101 as he is Sigma Lithium Director of Geology.

Mr. Zan has verified the technical data disclosed in this news release not related to the current mineral resource estimate disclosed herein.

ABOUT SIGMA LITHIUM

Sigma Lithium (NASDAQ: SGML, TSXV: SGML, BVMF: S2GM34) is a leading global lithium producer dedicated to powering the next generation of electric vehicle batteries with carbon neutral, socially and environmentally sustainable chemical-grade lithium concentrate.

The Company operates one of the world’s largest lithium production sites—the fifth-largest industrial-mineral complex for lithium oxide—at its Grota do Cirilo Operation in Brazil. Sigma Lithium is at the forefront of environmental and social sustainability in the electric vehicle battery materials supply chain, producing Quintuple Zero Green Lithium: net-zero carbon lithium made with zero dirty power, zero potable water, zero toxic chemicals, and zero tailings dams.

Sigma Lithium currently produces 270,000 tonnes of lithium oxide concentrate on an annualized basis (approximately 38,000–40,000 tonnes of LCE) at its state-of-the-art Greentech Industrial Lithium Plant. The Company is now constructing a second plant to double production capacity to 520,000 tonnes of lithium oxide concentrate (approximately 77,000–80,000 tonnes of LCE).

For more information about Sigma Lithium, visit our website 

Sigma Lithium
LinkedIn: Sigma Lithium
Instagram: @sigmalithium
Twitter: @SigmaLithium

FORWARD-LOOKING STATEMENTS

This news release includes certain “forward-looking information” under applicable Canadian and U.S. securities legislation, including but not limited to statements relating to timing and costs related to the general business and operational outlook of the Company, the environmental footprint of tailings and positive ecosystem impact relating thereto, donation and upcycling of tailings, timing and quantities relating to tailings and Green Lithium, achievements and projections relating to the Zero Tailings strategy, achievement of ramp-up volumes, production estimates and the operational status of the Grota do Cirilo Project, and other forward-looking information. All statements that address future plans, activities, events, estimates, expectations or developments that the Company believes, expects or anticipates will or may occur is forward-looking information, including statements regarding the potential development of mineral resources and mineral reserves which may or may not occur. Forward-looking information contained herein is based on certain assumptions regarding, among other things: general economic and political conditions; the stable and supportive legislative, regulatory and community environment in Brazil; demand for lithium, including that such demand is supported by growth in the electric vehicle market; the Company’s market position and future financial and operating performance; the Company’s estimates of mineral resources and mineral reserves, including whether mineral resources will ever be developed into mineral reserves; and the Company’s ability to operate its mineral projects including that the Company will not experience any materials or equipment shortages, any labour or service provider outages or delays or any technical issues. Although management believes that the assumptions and expectations reflected in the forward-looking information are reasonable, there can be no assurance that these assumptions and expectations will prove to be correct. Forward-looking information inherently involves and is subject to risks and uncertainties, including but not limited to that the market prices for lithium may not remain at current levels; and the market for electric vehicles and other large format batteries currently has limited market share and no assurances can be given for the rate at which this market will develop, if at all, which could affect the success of the Company and its ability to develop lithium operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, except as required by law. For more information on the risks, uncertainties and assumptions that could cause our actual results to differ from current expectations, please refer to the current annual information form of the Company and other public filings available under the Company’s profile at 


www.sedarplus.com


.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Financial Tables

The unaudited condensed interim consolidated financial statements for the periods ended March 31, 2025 and 2024 were reviewed by the Company’s independent auditor in accordance with IFRS Accounting Standards, as issued by the International Accounting Standards Board.

Figure 1: Consolidated Statements of Income (Loss) Summary


Consolidated Statements of Income (Loss)


Three Months Ended
June 30, 2025


Three Months Ended
June 30, 2024



($ 000s)


Net sales revenue


16,888


45,920

Cost of goods sold & distribution

(23,564)

(29,765)


Gross profit (loss)


(6,676)


16,155

Sales expense

(183)

(376)

G&A expense

(4,336)

(4,603)

Stock-based compensation (1)

(472)

(1,943)

ESG and other operating expenses

(8,491)

(3,627)


EBIT


(20,158)


5,606

Financial income and (expenses), net

1,299

(18,632)


Income (loss) before taxes


(18,859)


(13,026)

Income taxes and social contribution

2,178


Net Income (loss) for the period


(18,859)


(10,848)

Weighted average number of common shares outstanding

111,280

110,528


Earnings per share


$(0.17)


$(0.10)

(1)   Excluding stock-based compensation allocated to operating costs. Starting January 1, 2025, the Company began allocating stock-based compensation for certain operational personnel directly to operating costs, in alignment with revised internal cost attribution practices. This change reflects a more accurate representation of total operating expenses. Prior to 2025, these costs were reported under general and administrative expenses.

Figure 2: Consolidated Statements of Financial Position Summary


Consolidated Statements of Financial Position


As of June 30,
2025


As of December 31, 2024



($ 000s)


Assets

    Cash and cash equivalents

15,113

45,918

    Trade accounts receivable

16,765

11,583

    Inventories

24,566

16,140

    Other current assets

13,306

19,129


  Total current assets


69,750


92,771

    Property, plant and equipment

161,617

141,025

    Other non-current assets

104,834

93,322


  Total Assets


266,451


327,118

Liabilities & Shareholder Equity

    Financing and export prepayment

53,655

61,596

    Suppliers & accounts payable

44,325

32,627

    Other current liabilities

17,359

14,548


  Total current liabilities


115,339


108,771

    Financing and export prepayment

113,300

112,003

    Other non-current liabilities

15,639

14,004


  Total non-current liabilities


128,939


126,007


  Total shareholders’ equity


91,923


92,340


Total Liabilities & Shareholders’ Equity


336,201


327,118

Figure 3: Cash Flow Statement Summary


Consolidated Statements of Cash Flows


Six Months Ended June
30, 2025


Six Months Ended June
30, 2024



($ 000s)

Operating Activities


Net income (loss) for the period


(14,131)


(17,757)

    Adjustments, including FX movements

(18,703)

22,941

    Interest payment on loans and leases

6,644

(2,971)


  Adjustments to income (loss) for the period


(12,059)


19,970

    Change in working capital

3,854

(22,740)


Net Cash from Operating Activities


(8,205)


(42,710)

Investing Activities

  Purchase of PPE

(6,479)

(11,185)

  Addition to exploration and evaluation assets

(545)

(2,361)

  Other

(1,042)

(349)


Net Cash from Investing Activities


(8,066)


(13,895)

Financing Activities

  Proceeds of loans, net

(16,642)

93,768

  Other

(1,226)

(773)


Net Cash from Financing Activities


(17,868)


92,955

Effect of FX

3,344

(9,644)


Net (decrease) increase in cash


(30,805)


26,746

Cash & Equivalents, Beg of Period

45,918

48,584

Cash & Equivalents, End of Period

15,113

75,330

Footnotes:

To provide investors and others with additional information regarding the financial results of Sigma Lithium, we have disclosed in this release certain non-IFRS operating performance measures such as unit operating costs, EBITDA, EBITDA margin, Adjusted EBITDA, and Adjusted EBITDA margin. These non-IFRS financial measures are a supplement to and not a substitute for or superior to, the Company’s results presented in accordance with IFRS.  The non-IFRS financial measures presented by the Company may be different from non-GAAP/IFRS financial measures presented by other companies. Specifically, the Company believes the non-IFRS information provides useful measures to investors regarding the Company’s financial performance by excluding certain costs and expenses that the Company believes are not indicative of its core operating results. The presentation of these non-U.S. GAAP/IFRS financial measures is not meant to be considered in isolation or as a substitute for results or guidance prepared and presented in accordance with U.S. GAAP/IFRS.  A reconciliation of these financial measures to IFRS results is included herein.

1. Cash u
nit operating costs include mining, processing, and site based general and administration costs. It is calculated on an incurred basis, credits for any capitalised mine waste development costs, and it excludes depreciation, depletion and amortization of mine and processing associated activities. When reported on an FOB basis, this metric includes road freight, and port related charges. When reported on a CIF basis it includes ocean freight, insurance and royalty costs. Royalty costs include a 2% government royalty and a 1% private royalty.

For CIF operating cost analysis purposes, the Company uses the ocean freight costs of products that sailed during the reporting period. However, for accounting purposes, and therefore in this quarter’s reported cost of good sold and revenues, ocean freight is treated as a service provided to a customer and is recognized when the product is delivered.

Cash unit all-in sustaining cost includes unit CIF China cash operating cost, SG&A, maintenance capex and financial expenses.

2. Cash operating profit represents revenue less cost of sales (COGS), excluding depreciation and amortization (D&A) expenses. Cash operating margin is cash operating profit divided by total revenue for the period.

3. Average revenue per tonne is calculated as total revenue for the period divided by total sales volume in tonnes. Average COGS per tonne is calculated as total cost of sales (COGS) for the period divided by total sales volume in tonnes.

 4. Adjusted EBITDA is a measure of the Company’s recurring core earnings profile. It is calculated as revenue minus cash operating and selling expenses. The calculation excludes non-cash items such as depreciation and amortization (D&A) and stock-based compensation expenses. Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by total revenue for the period.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sigma-lithium-reports-2q25-results-delivers-on-target-production-further-cost-reductions-and-deleveraging-302530894.html

SOURCE Sigma Lithium Corporation

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

Propanc common stock expected to begin trading on Nasdaq under the symbol PPCB

MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock, par value $0.001 per share, at a price of $4.00 per share. The offering is expected to yield approximately $4 million in gross proceeds before offering expenses and underwriting discounts and commissions. Propanc intends to use the net proceeds from the offering for its working capital and general business purposes.

In connection with the offering, the Company has also granted the underwriter a 45-day option to purchase up to 150,000 additional shares of common stock. The offering is expected to close on August 18, 2025, subject to customary closing conditions. On August 14, 2025, the Company received approval to list its common stock on the Nasdaq Capital Market stock exchange (“Nasdaq”). Trading on Nasdaq is expected to commence on August 15, 2025, subject to continued compliance with the exchange rules.

The Company’s shares of common stock were previously quoted on the OTC Markets, Pink Tier and ceased to be quoted at the close of business on August 14, 2025.  Stockholders are not required to take any action as a result of the uplisting, and the Company’s ticker symbol “PPCB” will remain unchanged.

D. Boral Capital LLC and Craft Capital Management LLC are acting as book running managers for the offering.

A registration statement on Form S-1 relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on August 13, 2025. These securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The proposed offering will be made only by means of a prospectus. Electronic copies of the preliminary prospectus supplement and accompanying prospectus will also be available on the SEC’s website at http://www.sec.gov.

About Propanc Biopharma, Inc.

Propanc Biopharma, Inc. (the “Company”) is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from pancreatic, ovarian, and colorectal cancers. For more information, please visit www.propanc.com.

The Company’s novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body’s primary defense against cancer.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company’s expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors, made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are not historical facts but rather are based on the Company’s current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company’s control. Forward-looking statements are not guarantees of future actions or performance. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including, without limitation, risks and uncertainties related to market conditions, as well as those risks described under “Risk Factors” in the prospectus related to the proposed offering and those described in the Company’s filings with the SEC. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

Company:

Propanc Biopharma, Inc.
James Nathanielsz
+61-3-9882-0780
[email protected]
Investor Contact:
[email protected]



Robot Consulting Co., Ltd. Announces Fiscal Year 2025 Financial Results

PR Newswire


TOKYO
, Aug. 14, 2025 /PRNewswire/ — Robot Consulting Co., Ltd. (Nasdaq: LAWR) (the “Company” or “Robot Consulting”), a Japanese platform service provider focusing on human resource solutions with an intention to expand into legal technology and the metaverse, today announced its financial results for the fiscal year ended March 31, 2025.

Fiscal Year 2025 Financial Summary

  • Revenue was JPY675.6 million ($4.5 million) in the fiscal year ended March 31, 2025, compared to JPY693.1 million in the fiscal year ended March 31, 2024.
  • Gross profit was JPY671.6 million ($4.5 million) in the fiscal year ended March 31, 2025, compared to JPY673.3 million in the fiscal year ended March 31, 2024.
  • Net loss was JPY534.7 million ($3.6 million) in the fiscal year ended March 31, 2025, a decrease of 19.2% from JPY662.0 million in the fiscal year ended March 31, 2024.
  • Basic and diluted loss per share was JPY12.7 in the fiscal year ended March 31, 2025, compared to JPY16.1 in the fiscal year ended March 31, 2024.

Mr. Amit Thakur, Director and Chief Executive Officer of Robot Consulting, remarked, “In fiscal year 2025, we achieved notable progress in our software business while continuing to streamline our operations. Our software revenue increased by 101.0% year over year, driven by the continued adoption of our Labor Robot platform since its launch in 2023. This growth reinforces our commitment to delivering innovative solutions that meet evolving customer needs. We also achieved substantial cost improvements, with the cost of revenue down 80.2% and selling, general, and administrative expenses reduced by 8.3%, resulting in a narrower net loss compared to the prior fiscal year.

“A major recent milestone was our successful listing on the Nasdaq Capital Market under the ticker symbol ‘LAWR’ on July 17, 2025. We anticipate that this achievement will enhance our visibility with global investors, broaden our access to capital, and provide the Company with the resources needed to accelerate innovation.

“Looking ahead, we remain focused on growing the market reach of our products while enriching our product portfolio. We are currently in the process of developing and incorporating desired features to the prototype of Robot Lawyer, with a plan to launch it in November 2025. Together with our growth initiatives and supported by our ongoing operational improvements, we believe these efforts will position us to capture new opportunities, strengthen our market presence, and deliver sustainable value for our shareholders over the long term.”

Fiscal Year 2025 Financial Results


Revenue

Revenue was JPY675.6 million ($4.5 million) in the fiscal year ended March 31, 2025, a decrease of 2.5% from JPY693.1 million in the fiscal year ended March 31, 2024. The decrease was primarily driven by the following factors:

  • Revenue from sales of software was JPY151.0 million ($1.0 million) in the fiscal year ended March 31, 2025, an increase of 101.0% from JPY75.1 million in the fiscal year ended March 31, 2024. Since the Company released its software, Labor Robot, in 2023, the number of accumulated users increased, with more users as of the fiscal year ended March 31, 2025 compared to the prior fiscal year 2024, which resulted in higher revenue in the fiscal year ended March 31, 2025.
  • Revenue from consulting and support services was JPY524.6 million ($3.5 million) in the fiscal year ended March 31, 2025, a decrease of 15.1% from JPY618.0 million in the fiscal year ended March 31, 2024, as the Company discontinued the e-commerce store set-up services and had no revenue from such services during the fiscal year ended March 31, 2025.


Cost of Revenue

Cost of revenue was JPY3.9 million($26,000) in the fiscal year ended March 31, 2025, a decrease of 80.2% from JPY19.8 million in the fiscal year ended March 31, 2024. The decrease was primarily due to the discontinuation of e-commerce store set-up services, which had a higher cost of revenue relative to total revenue.


Gross Profit

Gross profit was JPY671.6 million ($4.5 million) in the fiscal year ended March 31, 2025, a decrease of 0.2% from JPY 673.3 million in the fiscal year ended March 31, 2024.


Operating Expenses

Operating expenses were JPY1,205.8 million ($8.0 million) in the fiscal year ended March 31, 2025, a decrease of 9.0% from JPY1,325.1 million in the fiscal year ended March 31, 2024.

  • Research and development expenses were JPY86.2 million ($0.6 million) in the fiscal year ended March 31, 2025, a decrease of 16.7% from JPY103.4 million in the fiscal year ended March 31, 2024. The decrease was primarily due to reduced software development costs related to Lawyer Robot incurred during the fiscal year ended March 31, 2024.
  • Selling, general, and administrative expenses were JPY1,119.6 million ($7.5 million) in the fiscal year ended March 31, 2025, a decrease of 8.3% from JPY1,221.6 million in the fiscal year ended March 31, 2024. The decrease was primarily due to lower audit-related expenses.


Other Income (Expenses), net and Interest Expenses

Other expenses were JPY0.5 million($3,000) in the fiscal year ended March 31, 2025, a decrease of 95% from JPY10.2 million in the fiscal year ended March 31, 2024. The decrease was primarily due to the impairment loss on investments as non-recurring expenses in the fiscal year ended March 31, 2024.


Net Loss

Net loss was JPY534.7 million ($3.6 million) in the fiscal year ended March 31, 2025, a decrease of 19.2% from JPY662.0 million in the fiscal year ended March 31, 2024.


Basic and Diluted Loss per Share

Basic and diluted loss per share was JPY12.7 in the fiscal year ended March 31, 2025, compared to JPY16.1 in the fiscal year ended March 31, 2024.

Financial Condition

As of March 31, 2025, the Company had cash and cash equivalents of JPY112.0 million, compared to JPY471.6 million as of March 31, 2024.

Net cash used in operating activities was JPY283.0 million in the fiscal year ended March 31, 2025, compared to JPY317.1 million in the fiscal year ended March 31, 2024.

Net cash used in investing activities was JPY13.1 million in the fiscal year ended March 31, 2025, compared to JPY8.9 million in the fiscal year ended March 31, 2024.

Net cash used in financing activities was JPY63.6 million in the fiscal year ended March 31, 2025, compared to net cash provided by financing activities of JPY346.4 million in the fiscal year ended March 31, 2024.

Exchange Rate Information

This announcement contains translations of certain JPY amounts into U.S. dollars for the convenience of the reader. Translations of amounts from JPY into U.S. dollars have been made at the exchange rate of JPY149.9 = $1.00, which was the foreign exchange rate on March 31, 2025 as reported by the Board of Governors of the Federal Reserve System in its weekly release on April 7, 2025.

About Robot Consulting
Co., Ltd.

Robot Consulting Co., Ltd. is a Japanese platform service provider focusing on human resource solutions with an intention to expand into legal technology and the metaverse. The Company’s major product, “Labor Robot,” is a cloud-based human resource management system that helps users track employee attendance, manage sales orders, and journalize accounting items. Robot Consulting also assists users with grant and subsidy applications and provides consulting and support services for digital transformation to small and medium-sized businesses. Robot Consulting also aims to create more software and services related to digital transformation, legal technology, and the metaverse. The Company is currently developing “Robot Lawyer,” which will enable users to pose metaverse-related legal questions on certain metaverse platforms through Robot Lawyer’s AI-powered chat interface, search legal precedents through an AI-driven search engine, and access lawyer matching services for further legal consultation. For more information, please visit the Company’s website: https://ir.robotconsulting.net.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may,” or other similar expressions in this prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission (“SEC”). Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov.

For more information, please contact:

Robot Consulting Co., Ltd.
Investor Relations Department
Email: [email protected]

Ascent Investor Relations LLC

Tina Xiao

Phone: +1-646-932-7242
Email: [email protected]

 


BALANCE SHEETS


As of March 31, 2025 and 2024


(Yen in thousands, except share data)


2025


2024


March 31,


2025


2024


ASSETS

Current Assets:

Cash and cash equivalents

¥

112,012

¥

471,648

Accounts receivable, net

21,412

84,424

Related party receivable

9,304

Deferred offering costs

131,035

67,470

Prepaid expenses and other current assets

13,041

76,538

Total Current Assets

277,500

709,384

Non-current Assets:

Restricted cash

19,470

19,470

Property and equipment, net

6,946

1,929

Operating lease right-of-use assets, net

880

6,778

Intangible assets, net

7,104

1,962

Investments – Non-current

134

134

Other assets

1,938

3,888

Total Assets

¥

313,972

¥

743,545


LIABILITIES AND SHAREHOLDERS’ DEFICIT

Current Liabilities:

Trade accounts payable

¥

113,962

¥

368,883

Other payable

58,150

64,765

Accrued expenses

1,614

936

Deferred revenue – Current

351,937

130,824

Current portion of operating lease liabilities

402

6,523

Total Current Liabilities

526,065

571,931

Non-current Liabilities:

Non-current operating lease liabilities

479

255

Deferred revenue – Non-current

412,996

268,589

Other liabilities

25,817

19,470

Total Liabilities

965,357

860,245

Commitments and contingencies (Note 10)

SHAREHOLDERS’ DEFICIT:

Ordinary share, JPY1.7 par value – 168,000,000 shares authorized as of
March 31, 2025 and 2024; 42,210,000 shares issued and outstanding as of
March 31, 2025 and 2024

70,350

70,350

Additional paid-in capital

1,060,750

1,060,750

Accumulated deficit

(1,782,485)

(1,247,800)

Total Shareholders’ Deficit

(651,385)

(116,700)

Total Liabilities & Shareholders’ Deficit

¥

313,972

¥

743,545

 


STATEMENTS OF OPERATIONS


For the Fiscal Years Ended March 31, 2025, 2024 and 2023


(Yen in thousands, except share and per share data)


2025


2024


2023


For the Fiscal Years Ended March 31,


2025


2024


2023


Restated

Revenue

¥

675,561

¥

693,104

¥

83,597

Cost of revenue

3,936

19,848

70,622

Gross profit

671,625

673,256

12,975

Operating expenses:

Research and development

86,158

103,440

138,322

Selling, General and Administrative Expenses

1,119,641

1,221,614

342,670

Total operating expenses

1,205,799

1,325,054

480,992

Loss from operations

(534,174)

(651,798)

(468,017)

Other income (expenses), net

(511)

(10,168)

(10,591)

Interest expenses

(25)

Loss before income taxes

(534,685)

(661,966)

(478,633)

Provision for income taxes

Net Loss

¥

(534,685)

¥

(661,966)

¥

(478,633)

Net loss per share attributable to shareholders, basic
and diluted

¥

(12.7)

¥

(16.1)

¥

(12.3)

Weighted-average shares outstanding used to
compute net loss
per share, basic and diluted

42,210,000

41,127,797

38,882,926

 


STATEMENTS OF CASH FLOWS


For the Fiscal Years Ended March 31, 2025, 2024, and 2023


(Yen in thousands)


2025


2024


2023


For the Fiscal Years Ended March 31,


2025


2024


2023


Restated


Cash flows from operating activities:

Net loss

¥

(534,685)

¥

(661,966)

¥

(478,633)

Adjustments to reconcile net loss to net cash used in operating
activities:

Depreciation and amortization

2,892

1,832

220

Noncash lease expenses

6,643

6,179

2,968

Loss on disposal of property and equipment

592

Impairment loss on investments

10,000

10,000

Change in allowance for credit losses

(7,044)

Accounts receivable

70,056

(2,441)

(81,983)

Related party receivable

9,304

(7,230)

(2,073)

Prepaid expenses and other current assets

63,495

(51,507)

(9,555)

Other Assets

1,950

(2,297)

(594)

Accounts payable and accrued expenses

(260,857)

220,609

189,607

Deferred revenue

365,520

175,942

219,185

Operating lease liabilities

(6,643)

(6,179)

(2,968)

Other liabilities

6,350

19,470

Net cash used in operating activities

(283,019)

(317,058)

(133,764)


Cash flows from investing activities:

Purchase of property and equipment

(7,587)

(3,339)

(437)

Purchase of intangible assets

(5,464)

(2,101)

Acquisition of investments

(10,000)

(10,134)

Proceeds from sales of investment

6,552

Net cash used in investing activities

(13,051)

(8,888)

(10,571)


Cash flows from financing activities:

Payment for deferred offering costs

(63,566)

(22,015)

(45,454)

Proceeds from stock issuance

338,600

335,500

Proceeds received for subscription receivable

29,834

17,327

Net cash provided by financing activities

(63,566)

346,419

307,373

Net increase in cash, cash equivalents and restricted
cash

(359,636)

20,473

163,038

Cash, cash equivalents and restricted cash at
beginning of period

491,118

470,645

307,607


Cash, cash equivalents and restricted cash at end
of period

¥

131,482

¥

491,118

¥

470,645


Reconciliation of cash, cash equivalents and
restricted cash

Cash and cash equivalents

¥

112,012

¥

471,648

¥

451,175

Restricted cash

19,470

19,470

19,470

Total cash, cash equivalents and restricted cash

¥

131,482

¥

491,118

¥

470,645

 

Cision View original content:https://www.prnewswire.com/news-releases/robot-consulting-co-ltd-announces-fiscal-year-2025-financial-results-302530797.html

SOURCE Robot Consulting Co., Ltd.

Clarivate Partners with the University of Melbourne to Transform Library Systems

PR Newswire

Delivering World-class Solutions and Services to Drive Academic Success


LONDON
, Aug. 14, 2025 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading provider of transformative intelligence, has signed an agreement with the University of Melbourne, Australia’s leading university, to provide a comprehensive suite of library solutions and services. The solutions include Alma, Primo, Leganto, Rapido and Library Open Workflows, encompassing library management systems, information resource discovery, sharing and subject reading lists. This collaboration will provide the University of Melbourne with a world-class library systems platform that is purpose-fit, efficient, and user-focused.

The solutions will enable library users to access resources through advanced discovery systems, streamline operations and enhance data-driven decision-making. By integrating academic artificial intelligence (AI) and linked data, these solutions will enhance teaching and learning, research and broader community scholarly experience.

Asaf Kline, Vice President of Academic Libraries solutions, Clarivate said: “The collaboration between the University of Melbourne and Clarivate dates back two decades. We are very proud to collaborate with the University again to transform its library systems and drive scholarly success. Our proven solutions enable libraries to enhance their operational efficiency and effectiveness, driving impactful change and delivering improved user experiences for both students and faculty. At Clarivate, we are always committed to helping academic institutions think forward by connecting them to trusted content, deep expertise and responsible innovation.”

Gwenda Thomas, Director, Scholarly Services and University Librarian at the University of Melbourne, said: “Our important work in Scholarly Services builds and manages one of the most diverse and significant collections of scholarly and research resources in Australia. The implementation of the Alma platform will align the University with leading institutions globally, as it is a proven, flexible, and integrated solution currently used by over 2,700 libraries worldwide.”

About Clarivate

Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare.

For more information, please visit www.clarivate.com 

Media contact:

Jack Wan, External Communications Director
[email protected] 

About the University of Melbourne
Established in 1853, the University of Melbourne is one of Australia’s oldest universities and the first in Victoria. Today, the University’s vibrant community comprises over 77,000 students, including 46 per cent international students from more than 150 countries, who are supported by over 13,000 academic and professional staff. A network of more than 500,000 alumni around the world attests to the transformative impact of a University of Melbourne education. The University is home to nine faculties with state-of-the-art facilities and a commitment to interdisciplinary collaboration, it remains a driving force in shaping the future through impactful research. The University’s commitment to excellence has earned its place among the world’s best universities, delivering education and research outcomes that are global in reach, ambition and impact.

Media contact:

[email protected] | +61 3 8344 4123

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-partners-with-the-university-of-melbourne-to-transform-library-systems-302530205.html

SOURCE Clarivate Plc

Unitil Announces Pricing of Common Stock Offering

HAMPTON, N.H., Aug. 14, 2025 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) (the “Company”) today announced that it has priced its previously announced public offering of 1,393,355 shares of its common stock at a price of $46.65 per share. The offering is expected to close on August 18, 2025, subject to customary closing conditions.

The Company has granted the underwriters of the offering an option to purchase up to an additional 209,003 shares of common stock at the public offering price, less underwriting discounts and commissions.

The Company intends to use the net proceeds from the offering to (i) make equity capital contributions to its regulated utility subsidiaries, (ii) to repay indebtedness outstanding under its Second Amendment to Third Amended and Restated Credit Agreement dated January 29, 2025 among the Company, Bank of America, N.A. (as administrative agent), and the lenders named therein and (iii) for general corporate purposes.

Wells Fargo Securities, LLC and Scotia Capital (USA) Inc. are acting as active bookrunners for the offering. Janney Montgomery Scott LLC is acting as bookrunner for the offering.

The offering of common stock is being made by means of a prospectus supplement under the Company’s effective registration statement on Form S-3ASR, as filed with the Securities and Exchange Commission (“SEC”).

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor does it constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale is unlawful. The offering may be made only by means of a prospectus supplement relating to such offering and the accompanying prospectus. The preliminary prospectus supplement and the accompanying prospectus related to the offering will be available on the SEC’s website at http://www.sec.gov. To obtain a copy of the prospectus supplement and related base prospectus for this offering, please contact Wells Fargo Securities, LLC, 90 South 7th Street, 5th Floor, Minneapolis, MN 55402, at (800)-645-3751 (option #5) or email a request to [email protected].

About Unitil Corporation

Unitil Corporation provides energy for life by safely and reliably delivering electricity and natural gas in New England. We are committed to the communities we serve and to developing people, business practices, and technologies that lead to the delivery of dependable, more efficient energy. Unitil Corporation is a public utility holding company with operations in Maine, New Hampshire and Massachusetts. Together, Unitil’s operating utilities serve approximately 109,400 electric customers and 97,600 natural gas customers. For more information about our people, technologies, and community involvement please visit unitil.com.

Forward-Looking Statements

This press release contains forward-looking statements. All statements, other than statements of historical fact, included in this press release are forward-looking statements. Forward-looking statements include declarations regarding Unitil’s beliefs and current expectations. These forward-looking statements are subject to the inherent risks and uncertainties in predicting future results and conditions that could cause the actual results to differ materially from those projected in these forward-looking statements. Some, but not all, of the risks and uncertainties include the following: the ability of the parties to consummate the offering in a timely manner or at all; Unitil’s regulatory environment (including regulations relating to climate change, greenhouse gas emissions and other environmental matters); fluctuations in the supply of, the demand for, and the prices of, energy commodities and transmission and transportation capacity and Unitil’s ability to recover energy commodity costs in its rates; customers’ preferred energy sources; severe storms and Unitil’s ability to recover storm costs in its rates; general economic conditions; variations in weather; long-term global climate change; unforeseen or changing circumstances, which could adversely affect the reduction of company-wide direct greenhouse gas emissions; Unitil’s ability to retain its existing customers and attract new customers; increased competition; and other risks detailed in Unitil’s filings with the SEC. These forward-looking statements speak only as of the date they are made. Unitil undertakes no obligation, and does not intend, to update these forward-looking statements except as required by law.

For more information please contact: 

Christopher Goulding – Investor Relations
Phone: 603-773-6466
Email: [email protected]        



Accenture to Acquire CyberCX, Expanding Cybersecurity Capabilities in Asia Pacific

Accenture to Acquire CyberCX, Expanding Cybersecurity Capabilities in Asia Pacific

Accenture will accelerate business growth and client cyber resilience with CyberCX’s approximately 1,400 skilled cybersecurity professionals and AI-powered security platforms

NEW YORK & MELBOURNE, Australia–(BUSINESS WIRE)–
Accenture (NYSE: ACN) has agreed to acquire CyberCX, a leading privately-owned cybersecurity services provider serving both private and public sector organizations across Australia, New Zealand and internationally. The move represents Accenture’s largest cybersecurity acquisition to date and will significantly bolster Accenture’s cybersecurity services in Asia Pacific. It will further expand Accenture’s leading position in the region, enhancing its ability to build business resilience, protect critical infrastructure and drive secure enterprise reinvention amidst an increasingly complex regulatory and threat landscape.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814025867/en/

Accenture has agreed to acquire CyberCX, a leading privately-owned cybersecurity services provider serving both private and public sector organizations across Australia, New Zealand and internationally.

Accenture has agreed to acquire CyberCX, a leading privately-owned cybersecurity services provider serving both private and public sector organizations across Australia, New Zealand and internationally.

Established in Melbourne, Australia in 2019, CyberCX is one of the largest and most prominent cybersecurity firms in the Asia Pacific region with a highly skilled workforce of approximately 1,400 professionals. The company’s end-to-end services extend across consulting, transformation and managed security services and include advanced capabilities in offensive security and cyber physical security, crisis management, threat intelligence, managed detection and response, as well as strategic advisory, identity, cloud and network security. CyberCX operates a network of advanced security operations centers across Australia and New Zealand, with additional offices in London and New York, combining deep local insight with international reach.

Additionally, CyberCX brings innovative AI-powered platforms that deliver cybersecurity services including detection and response, sovereign secure cloud, CyberCX Academy for training and learning as well as proprietary tools for security testing and cyber intelligence.

This strategic move is timely given Accenture’s recent State of Cybersecurity Resilience 2025 report, which found that 97% of Australian organizations are not adequately prepared to secure their AI-driven future, with 80% lacking the critical data and AI cybersecurity practices needed to protect models, data pipelines and cloud infrastructure.

“CyberCX and Accenture share a mission to harness the power of cyber to help our clients securely navigate change, accelerate business reinvention and build resilience against evolving threats,” said Paolo Dal Cin, global lead, Accenture Cybersecurity. “By combining Accenture’s agentic AI capabilities with CyberCX’s strong market leadership, innovative offerings and trusted C-suite and government relationships, we will enable clients across Asia Pacific to transform cybersecurity into a strategic advantage.”

CyberCX has established strong ecosystem partnerships across major cybersecurity players such as Microsoft, Palo Alto Networks and CrowdStrike, consistently winning awards as one of the top managed service and system integrators in the region. This success is underpinned by extensive expertise, showcased through over 2,600 certifications.

“Client demand for cybersecurity services is accelerating as data and digital environments become increasingly connected and heightened threats are exposed across operational value chains, supply chains and the enterprise. The need for responsible governance is also rising as AI and Quantum technologies advance,” said Peter Burns, who leads Accenture’s business in Australia and New Zealand. “CyberCX’s breadth of capabilities, trusted relationships with government and critical infrastructure organizations, and exceptional talent in the region, combined with Accenture’s local and global scale and innovation, will help us meet this ever-increasing client need.”

John Paitaridis, CEO of CyberCX, said, “We are immensely proud of the business we have built, becoming one of the leading providers of cybersecurity services in the region. Joining Accenture’s global cybersecurity organization enables our exceptional people to combine forces with global capabilities and provide world-leading cybersecurity services to an even greater number of clients across Asia Pacific as we accelerate our growth in the region. Our shared mission for helping clients stay ahead of emerging threats and build resilience makes this a force multiplier.”

The acquisition of CyberCX will be the latest in a series of strategic moves by Accenture to expand its cybersecurity capabilities and solutions. Since 2015, Accenture has completed 20 security acquisitions, including most recently acquiring Morphus, MNEMO Mexico and Innotec Security.

Terms of the transaction were not disclosed. Completion of the acquisition is subject to customary closing conditions, including receipt of regulatory approvals.

Forward-Looking Statements

Except for the historical information and discussions contained herein, statements in this news release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “likely,” “anticipates,” “aspires,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “positioned,” “outlook,” “goal,” “target” and similar expressions are used to identify these forward-looking statements. These statements are not guarantees of future performance nor promises that goals or targets will be met, and involve a number of risks, uncertainties and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or implied. These risks include, without limitation, risks that: Accenture and CyberCX will not be able to close the transaction in the time period anticipated, or at all, which is dependent on the parties’ ability to satisfy certain closing conditions; the transaction might not achieve the anticipated benefits for Accenture; Accenture’s results of operations have been, and may in the future be, adversely affected by volatile, negative or uncertain economic and geopolitical conditions and the effects of these conditions on the company’s clients’ businesses and levels of business activity; Accenture’s business depends on generating and maintaining client demand for the company’s services and solutions including through the adaptation and expansion of its services and solutions in response to ongoing changes in technology and offerings, and a significant reduction in such demand or an inability to respond to the evolving technological environment could materially affect the company’s results of operations; risks and uncertainties related to the development and use of AI could harm the company’s business, damage its reputation or give rise to legal or regulatory action; if Accenture is unable to match people and their skills with client demand around the world and attract and retain professionals with strong leadership skills, the company’s business, the utilization rate of the company’s professionals and the company’s results of operations may be materially adversely affected; Accenture faces legal, reputational and financial risks from any failure to protect client and/or company data from security incidents or cyberattacks; the markets in which Accenture operates are highly competitive, and Accenture might not be able to compete effectively; Accenture’s ability to attract and retain business and employees may depend on its reputation in the marketplace; if Accenture does not successfully manage and develop its relationships with key ecosystem partners or fails to anticipate and establish new alliances in new technologies, the company’s results of operations could be adversely affected; Accenture’s profitability could materially suffer due to pricing pressure, if the company is unable to remain competitive, if its cost-management strategies are unsuccessful or if it experiences delivery inefficiencies or fail to satisfy certain agreed-upon targets or specific service levels; changes in Accenture’s level of taxes, as well as audits, investigations and tax proceedings, or changes in tax laws or in their interpretation or enforcement, could have a material adverse effect on the company’s effective tax rate, results of operations, cash flows and financial condition; Accenture’s results of operations could be materially adversely affected by fluctuations in foreign currency exchange rates; Accenture’s debt obligations could adversely affect its business and financial condition; changes to accounting standards or in the estimates and assumptions Accenture makes in connection with the preparation of its consolidated financial statements could adversely affect its financial results; as a result of Accenture’s geographically diverse operations and strategy to continue to grow in key markets around the world, the company is more susceptible to certain risks; if Accenture is unable to manage the organizational challenges associated with its size, the company might be unable to achieve its business objectives; Accenture might not be successful at acquiring, investing in or integrating businesses, entering into joint ventures or divesting businesses; Accenture’s business could be materially adversely affected if the company incurs legal liability; Accenture’s work with government clients exposes the company to additional risks inherent in the government contracting environment; Accenture’s global operations expose the company to numerous and sometimes conflicting legal and regulatory requirements; if Accenture is unable to protect or enforce its intellectual property rights or if Accenture’s services or solutions infringe upon the intellectual property rights of others or the company loses its ability to utilize the intellectual property of others, its business could be adversely affected; Accenture may be subject to criticism and negative publicity related to its incorporation in Ireland; as well as the risks, uncertainties and other factors discussed under the “Risk Factors” heading in Accenture plc’s most recent Annual Report on Form 10-K, as updated in Item 1A, “Risk Factors” in its Quarterly Report on Form 10-Q for the second quarter of fiscal 2025, and other documents filed with or furnished to the Securities and Exchange Commission. Statements in this news release speak only as of the date they were made, and Accenture undertakes no duty to update any forward-looking statements made in this news release or to conform such statements to actual results or changes in Accenture’s expectations.

About Accenture

Accenture is a leading global professional services company that helps the world’s leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale. We are a talent- and innovation-led company with approximately 791,000 people serving clients in more than 120 countries. Technology is at the core of change today, and we are one of the world’s leaders in helping drive that change, with strong ecosystem relationships. We combine our strength in technology and leadership in cloud, data and AI with unmatched industry experience, functional expertise and global delivery capability. Our broad range of services, solutions and assets across Strategy & Consulting, Technology, Operations, Industry X and Song, together with our culture of shared success and commitment to creating 360° value, enable us to help our clients reinvent and build trusted, lasting relationships. We measure our success by the 360° value we create for our clients, each other, our shareholders, partners and communities. Visit us at accenture.com.

Accentureis a leading provider of end-to-end cybersecurity services, including strategy, protection, resilience and industry-specific cyber services. We bring security innovation, coupled with global scale and a worldwide delivery capability through our network of Cyber Fusion Centers. Helped by our team of 29,000 highly skilled specialists, we enable clients to innovate safely, build cyber resilience and grow with confidence. Visit us at https://www.accenture.com/cybersecurity.

Copyright © 2025 Accenture. All rights reserved. Accenture and its logo are registered trademarks of Accenture.

Alison Geib

Accenture

+1 703 947 4404

[email protected]

Kate Maher

Accenture Australia

+61 405 778 205

[email protected]

KEYWORDS: North America United States Asia Pacific Australia Australia/Oceania New York

INDUSTRY KEYWORDS: Data Management Security Technology Software Networks Artificial Intelligence

MEDIA:

Photo
Photo
Accenture has agreed to acquire CyberCX, a leading privately-owned cybersecurity services provider serving both private and public sector organizations across Australia, New Zealand and internationally.

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025


Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer

24/7 Market News Issues Corrected Information on Previously issued Press Release with same title

DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, spotlights LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage pharmaceutical company focused on developing novel cancer therapies by targeting the modulation of key cellular pathways.

2H 2025 is shaping up to be a defining year for LIXTE. With a focus on its lead compound LB-100, a first-in-class small molecule inhibitor of protein phosphatase 2A (PP2A), a master regulator of cell signaling and DNA damage response. By inhibiting PP2A, LB-100 sensitizes tumors to DNA-damaging agents, including chemotherapy, radiation, and immunotherapy, LIXTE is targeting high-unmet needs in the $200 billion global oncology market (Grand View Research, 2025 projection). Potential upcoming catalysts in 2025, including a first trial result, position LIXTE as a potential disruptor in resistant cancers, where traditional treatments fail due to limited efficacy and toxicity.

Upcoming Catalysts: Anticipated Trial Results in 2H 2025

1B/2 Trial – Ovarian Clear Cell Carcinoma (OCCC)

Ovarian clear cell carcinoma is an aggressive and chemoresistant subtype of epithelial ovarian cancer, accounting for ~5–10% of all ovarian malignancies but disproportionately contributing to ovarian cancer mortality.

The Phase 1B/2 study of LB-100 plus the checkpoint inhibitor dostarlimab (GSK) is designed leverage LB-100’s synergistic enhancement of immune checkpoint blockade.

  • Status: Enrolled, with interim safety completed
  • Upcoming Milestone: Preliminary safety and efficacy data expected Q4 2025
  • Potential Market Impact: Global OCCC treatment market is projected to exceed $750 million by 2028 due to rising incidence and limited targeted therapies

1B/2 Trial – Advanced Soft Tissue Sarcoma (STS)

Soft tissue sarcomas are a diverse and difficult-to-treat group of cancers arising from connective tissues. For patients with advanced or metastatic disease, prognosis remains poor.
LIXTE’s Phase 1B/2 study evaluates LB-100 in combination with doxorubicin, the current standard of care, in patients with advanced STS.

  • Status: Dose escalation completed.
  • Upcoming Milestone: Safety report Q4 2025
  • Potential Market Impact: The global STS drug market is estimated to reach $2.1 billion by 2030, driven by the emergence of combination therapies and unmet medical need

1B Trial – Metastatic Microsatellite Stable (MSS) Colon Cancer

MSS colon cancer, representing roughly 85% of metastatic colorectal cancer (mCRC), remains unresponsive to checkpoint inhibitors.

LIXTE is conducting a Phase 1B trial assessing the safety and activity of LB-100 in combination with+ atezolizumab (Roche) (an ICI), seeking to overcome immune resistance in this cold tumor type.

  • Status: Trial open, first patients recruited
  • Potential Market Impact: The global colorectal cancer therapeutics market is expected to surpass $18 billion by 2030, with MSS disease representing the majority of treatment-resistant cases

Platform Potential and Market Opportunity

LIXTE’s strategy of targeting PP2A to potentiate multiple treatment modalities positions LB-100 as a versatile combination agent with broad applicability across solid tumors. The platform’s potential spans oncology subtypes with high unmet need, limited innovation, and growing incidence.

  • Strong IP Position: Multiple issued and pending patents covering composition, methods of use, and combinations
  • Pipeline Expansion: Additional tumor types and investigator-sponsored studies are under review, including glioblastoma.
  • Partnership Potential: Ongoing discussions with academic institutions and biopharma partners for co-development opportunities

Contact [email protected] for Analyst Report coverage and other investor/public relations services.

About LIXTE Biotechnology Holdings, Inc.

LIXTE is a clinical-stage pharmaceutical company focused on discovering and developing innovative cancer therapies targeting the protein phosphatase 2A (PP2A) pathway, a previously underexplored avenue in cancer treatment. The company’s lead compound, LB-100, is a first-in-class PP2A inhibitor that has demonstrated strong preclinical results and early-stage clinical tolerability. LIXTE is currently advancing proof-of-concept trials in Ovarian Clear Cell Carcinoma, Metastatic Colon Cancer, and Advanced Soft Tissue Sarcoma.

More information can be found at: www.lixte.com

24/7 MARKET NEWS, INC Disclaimer

Please go to https://247marketnews.com/lixte-biotechnology/ for further LIXT information and 247marketnews.com LIXT disclosure information.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.



CONTACT:
24/7 Market News
[email protected]